AbbVie Inc. (4AB.DE)

EUR 157.6

(-0.13%)

Eps Summary of AbbVie Inc.

AbbVie Inc.'s latest annual eps in 2023 was 2.70 USD , down -58.89% from previous year.
AbbVie Inc.'s latest quarterly eps in 2024 Q2 was 0.72 USD , down -2.56% from previous quarter.
AbbVie Inc. reported an annual eps of 6.69 USD in 2022, up 2.45% from previous year.
AbbVie Inc. reported an annual eps of 6.53 USD in 2021, up 149.24% from previous year.
AbbVie Inc. reported a quarterly eps of 0.78 USD for 2024 Q1, up 65.96% from previous quarter.
AbbVie Inc. reported a quarterly eps of 1.14 USD for 2023 Q2, up 714.29% from previous quarter.

Annual Eps Chart of AbbVie Inc. (2023 - 2009)

Historical Annual Eps of AbbVie Inc. (2023 - 2009)

Year	Eps	Eps Growth
2023	2.70 USD	-58.89%
2022	6.69 USD	2.45%
2021	6.53 USD	149.24%
2020	2.62 USD	-50.84%
2019	5.33 USD	38.44%
2018	3.85 USD	15.62%
2017	3.33 USD	-10.96%
2016	3.74 USD	16.88%
2015	3.20 USD	188.29%
2014	1.11 USD	-57.31%
2013	2.60 USD	-22.39%
2012	3.35 USD	58.02%
2011	2.12 USD	-18.15%
2010	2.59 USD	-9.76%
2009	2.87 USD	0.0%

Year	Eps	Eps Growth
2024 Q2	0.72 USD	-2.56%
2024 Q1	0.78 USD	65.96%
2023 Q2	1.14 USD	714.29%
2023 Q4	0.47 USD	-53.47%
2023 FY	- USD	-58.89%
2023 Q3	1.01 USD	-11.4%
2023 Q1	0.14 USD	-90.0%
2022 FY	- USD	2.45%
2022 Q4	1.40 USD	-36.94%
2022 Q3	2.22 USD	326.92%
2022 Q2	0.52 USD	-79.37%
2022 Q1	2.52 USD	10.04%
2021 Q2	0.43 USD	-78.61%
2021 FY	- USD	149.24%
2021 Q3	1.80 USD	318.6%
2021 Q4	2.29 USD	27.22%
2021 Q1	2.01 USD	9752.94%
2020 FY	- USD	-50.84%
2020 Q3	1.31 USD	411.9%
2020 Q4	0.02 USD	-98.44%
2020 Q1	2.04 USD	7.94%
2020 Q2	-0.42 USD	-120.59%
2019 Q4	1.89 USD	48.82%
2019 Q2	0.50 USD	-69.88%
2019 FY	- USD	38.44%
2019 Q1	1.66 USD	234.96%
2019 Q3	1.27 USD	154.0%
2018 Q1	1.75 USD	5251.68%
2018 Q2	1.31 USD	-25.14%
2018 FY	- USD	15.62%
2018 Q3	1.83 USD	39.69%
2018 Q4	-1.23 USD	-167.21%
2017 Q3	1.02 USD	-15.0%
2017 FY	- USD	-10.96%
2017 Q4	0.03 USD	-96.79%
2017 Q1	1.08 USD	24.14%
2017 Q2	1.20 USD	11.11%
2016 Q1	0.84 USD	-10.64%
2016 FY	- USD	16.88%
2016 Q3	0.98 USD	-1.01%
2016 Q2	0.99 USD	17.86%
2016 Q4	0.87 USD	-11.22%
2015 Q3	0.76 USD	-8.43%
2015 Q2	0.83 USD	29.69%
2015 Q1	0.64 USD	225.49%
2015 Q4	0.94 USD	23.68%
2015 FY	- USD	188.29%
2014 Q1	0.62 USD	-12.68%
2014 Q3	0.32 USD	-53.62%
2014 Q4	-0.51 USD	-259.38%
2014 FY	- USD	-57.31%
2014 Q2	0.69 USD	11.29%
2013 Q1	0.61 USD	-29.89%
2013 Q2	0.67 USD	9.84%
2013 Q3	0.61 USD	-8.96%
2013 Q4	0.71 USD	16.39%
2013 FY	- USD	-22.39%
2012 Q3	1.00 USD	28.21%
2012 FY	- USD	58.02%
2012 Q4	0.87 USD	-13.0%
2012 Q1	0.55 USD	-15.38%
2012 Q2	0.78 USD	41.82%
2011 Q4	0.65 USD	9185.71%
2011 Q3	0.01 USD	-99.2%
2011 Q2	0.87 USD	93.33%
2011 Q1	0.45 USD	0.0%
2011 FY	- USD	-18.15%
2010 FY	- USD	-9.76%
2009 FY	- USD	0.0%

Peer Eps Comparison of AbbVie Inc.

Name	Eps	Eps Difference
Bayer Aktiengesellschaft	-2.99 EUR	190.301%
Sanofi	4.31 EUR	37.355%